TY - JOUR
T1 - Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction
T2 - trials and tribulations
AU - Hausenloy, Derek J
AU - Botker, Hans Erik
AU - Engstrom, Thomas
AU - Erlinge, David
AU - Heusch, Gerd
AU - Ibanez, Borja
AU - Kloner, Robert A
AU - Ovize, Michel
AU - Yellon, Derek M
AU - Garcia-Dorado, David
PY - 2017/4/1
Y1 - 2017/4/1
KW - Adenosine/therapeutic use
KW - Cardiotonic Agents/therapeutic use
KW - Clinical Trials as Topic/methods
KW - Combined Modality Therapy
KW - Coronary Vessels/physiology
KW - Cyclosporine/therapeutic use
KW - Enzyme Inhibitors/therapeutic use
KW - Humans
KW - Hypothermia, Induced/methods
KW - Ischemic Postconditioning/methods
KW - Metoprolol/therapeutic use
KW - Mitochondrial Membrane Transport Proteins/physiology
KW - Mitochondrial Permeability Transition Pore
KW - Myocardial Reperfusion/adverse effects
KW - Myocardial Reperfusion Injury/etiology
KW - Nitric Oxide/metabolism
KW - Nitrites/therapeutic use
KW - Nucleotides, Cyclic/metabolism
KW - Oligopeptides/therapeutic use
KW - Oximes/therapeutic use
KW - Patient Selection
KW - Protein Kinase C/antagonists & inhibitors
KW - ST Elevation Myocardial Infarction/complications
KW - Secosteroids/therapeutic use
KW - Signal Transduction/physiology
KW - Vasodilator Agents/therapeutic use
U2 - 10.1093/eurheartj/ehw145
DO - 10.1093/eurheartj/ehw145
M3 - Journal article
C2 - 27118196
SN - 0195-668X
VL - 38
SP - 935
EP - 941
JO - European Heart Journal
JF - European Heart Journal
IS - 13
ER -